Lyphe group
Seedtable Score
37
Startups
1
Funding Rounds
1
Investors
$6.22m
Money raised
Overview
Lyphe Group, based in London, has significant potential in the growing medical cannabis market. The company focuses on supplying medical cannabis care and medication to other businesses, distinguishing itself with regulated and compliant solutions. This sets it apart from unregulated sources and traditional pharmaceuticals. By ensuring compliance with legal standards, Lyphe Group addresses limited access issues many patients face regarding medical cannabis. However, they must stay vigilant about the legal landscape and compliance risks in the sector. Backed by investors like Leafy Tunnel, Lyphe Group is well-positioned to expand in this evolving market niche.
- Website: https://LYPHEGROUP.com
- Business model: b2b
- Company size: 51 - 101 employees
- Headquarters: London, UK
- Founded: 2018
- Social accounts: Twitter Linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
Investors (1)
Funding
Funding series
Funding Series Analysis
The company Lyphe group has raised a total of $6.22m in funding over 1 rounds.
Key Insights:
- Series A: $6.22m
Lyphe group Series A (2022, $6M)
$6.22m